Which has grown faster, KYNB or TXMD?

Neither grew: over the past five years both shrank revenue, with TXMD's decline the smaller — KYNB at a -51.49% CAGR versus TXMD at -47.86%.

Is KYNB or TXMD more profitable?

KYNB runs the higher net margin — KYNB at 3967.77% versus TXMD at -6.64%.

How have KYNB and TXMD total returns compared?

Over the past 10 years, KYNB delivered -35.88% and TXMD delivered -40.05% annualized total return. Past performance doesn't predict future results.

Kyntra Bio, Inc. (KYNB) vs TherapeuticsMD, Inc. (TXMD)

A side-by-side comparison of Kyntra Bio, Inc. and TherapeuticsMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

KYNB

Kyntra Bio, Inc.

$24M

$5.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TXMD

TherapeuticsMD, Inc.

$23M

$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — KYNB vs TXMD

growth of $100 · dividends reinvested · last 10y

KYNB -98.8% (-35.8%/yr)TXMD -99.4% (-40.0%/yr)KYNB compounded faster over this window

KYNB TXMD

KYNB vs TXMD: by the numbers

•KYNB is the larger company ($24M vs $23M market cap).
•KYNB is profitable (3967.77% net margin) while TXMD runs a net loss (-6.64%).
•Both shrank revenue over the past five years; TXMD's decline was smaller (-47.86% vs -51.49% CAGR).

Metrics side by side

Valuation

Metric	KYNB	TXMD
Forward P/E	N/A	11.88
P/S ratio	5.23	7.15
P/B ratio	N/A	0.86
FCF yield	N/A	13.34%

Profitability

Metric	KYNB	TXMD
Gross margin	91.37%	100.00%
Operating margin	-712.66%	-139.44%
Net margin	3967.77%	-6.64%
ROE	N/A	-0.80%
ROIC	-78.16%	-11.84%

Growth (annualized)

Metric	KYNB	TXMD
Revenue CAGR (5Y)	-51.49%	-47.86%
Total return CAGR (5Y)	-52.67%	-44.16%

Frequently asked

Which has grown faster, KYNB or TXMD?: Neither grew: over the past five years both shrank revenue, with TXMD's decline the smaller — KYNB at a -51.49% CAGR versus TXMD at -47.86%.
Is KYNB or TXMD more profitable?: KYNB runs the higher net margin — KYNB at 3967.77% versus TXMD at -6.64%.
How have KYNB and TXMD total returns compared?: Over the past 10 years, KYNB delivered -35.88% and TXMD delivered -40.05% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KYNB analysis Full TXMD analysis Interactive comparison tool

Dig into the metrics

Kyntra Bio ROE TherapeuticsMD ROE Kyntra Bio operating margin TherapeuticsMD operating margin Kyntra Bio revenue growth TherapeuticsMD revenue growth Kyntra Bio free cash flow TherapeuticsMD free cash flow

Kyntra Bio & TherapeuticsMD appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.